Abstract
Background
The role of human papillomavirus (HPV) on head and neck squamous cell carcinoma (HNSCC) survival in regions with low HPV prevalence is not yet clear. We evaluated the HPV16 infection on survival of HNSCC Brazilian patient series.
Methods
This cohort comprised 1,093 HNSCC cases recruited from 1998 to 2008 in four Brazilian cities and followed up until June 2009. HPV16 antibodies were analyzed by multiplex Luminex assay. In a subset of 398 fresh frozen or paraffin blocks of HNSCC specimens, we analyzed for HPV16 DNA by L1 generic primer polymerase chain reaction. HNSCC survival according to HPV16 antibodies was evaluated through Kaplan–Meier method and Cox regression.
Results
Prevalence of HPV16 E6 and E6/E7 antibodies was higher in oropharyngeal cancer than in other head and neck tumor sites. HPV16 DNA positive in tumor tissue was also higher in the oropharynx. Seropositivity for HPV16 E6 antibodies was correlated with improved HNSCC survival and oropharyngeal cancer. The presence of HPV16 E6/E7 antibodies was correlated with improved HNSCC survival and oropharyngeal cancer survival. The death risk of oropharyngeal squamous cell carcinoma patients HPV16 E6/E7 antibodies positive was 78 % lower than to those who test negative.
Conclusion
Oropharyngeal squamous cell carcinoma is less aggressive in the HPV16 E6/E7 positive serology patients. HPV16 E6/E7 antibody is a clinically sensible surrogate prognostic marker of oropharyngeal squamous cell carcinoma.
Similar content being viewed by others
References
Argiris A, Karamouzis MV, Raben D, Ferris RL (2008) Head and neck cancer. Lancet 371:1695–1709
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No 10 [Internet]. Lyon, France: International Agency for Research on Cancer; [cited 2012 Aug 30]. http://globocan.iarc.fr
Carvalho AL, Ikeda MK, Magrin J, Kowalski LP (2004) Trends of oral and oropharyngeal cancer survival over five decades in 3267 patients treated in a single institution. Oral Oncol 40:71–76
Szymanska K, Hung RJ, Wünsch Filho V, Eluf Neto J, Curado MP, Koifman S et al (2011) Alcohol and tobacco, and the risk of cancers of the upper aerodigestive tract in Latin America: a case–control study. Cancer Causes Control 22:1037–1046
Human papillomaviruses (2007) Lyon, France: International Agency for Research on Cancer- IARC Monograph on the Evaluation of Carcinogenic Risks to Humans
Herrero R, Castellsagué X, Pawlita M, Lissowska J, Kee F, Balaram P et al (2003) Human papillomavirus and oral cancer: The International Agency for Research on Cancer Multicenter Study. J Natl Cancer Inst 95:1772–1783
Smith EM, Ritchie JM, Pawlita M, Rubenstein LM, Haugen TH, Turek LP et al (2006) Human papillomavirus seropositivity and risks of head and neck cancer. Int J Cancer 120:825–832
D’Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM et al (2007) Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356:1944–1956
Näsman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G et al (2009) Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 125:362–366
Ribeiro KB, Levi JE, Pawlita M, Koifman S, Matos E, Eluf-Neto J et al (2011) Low human papillomavirus prevalence in head and neck cancer: results from two large case–control studies in high-incidence regions. Int J Epidemiol 40:489–502
Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H et al (2008) Improved survival of patients with human papillomavirus–positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100:261–269
Smith EM, Rubenstein LM, Ritchie JM, Lee JH, Haugen TH, Hamsikova E et al (2008) Does treatment seropositivity to human papillomavirus have prognostic significance for head and neck cancers? Cancer Epidemiol Biomarkers Prev 17:2087–2096
Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24–35
Liang C, Marsit CJ, McClean MD, Nelson HH, Christensen BC, Haddad RI et al (2012) Biomarkers of HPV in head and neck squamous cell carcinoma. Cancer Res 72:5004–5013
World Health Organization (1992) International statistical classification of diseases and related health problems. 10th rev. World Health Organization, Washington, DC
Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado MP et al (2007) Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst 99:777–789
Sobin LH, Wittekind C (2002) TNM classification of malignant tumours. International Union Against Cancer, 6th edn. Wiley-Liss, New York
Kleter B, Van Doorn LJ, Schrauwen L, Molijn A, Sastrowijoto S, Ter Schegget J et al (1999) Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 37:2508–2517
Coutlée F, Gravitt P, Kornegay J, Hankins C, Richardson H, Lapointe N et al (2002) Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol 40:902–907
Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H et al (1994) Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infec Dis 170:1077–1085
Sehr P, Zumbach K, Pawlita M (2001) A generic capture ELISA for recombinant proteins fused to glutathione-S-transferase: validation for HPV serology. J Immunol Methods 253:153–162
Waterboer T, Sehr P, Michael KM, Franceschi S, Nieland JD, Joos TO et al (2005) Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem 51:1845–1853
Clifford GM, Shin HR, Oh JK, Waterboer T, Ju YH, Vaccarella S et al (2007) Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea. Cancer Epidemiol Biomarkers Prev 16:1874–1879
Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14:467–475
Dayyani F, Etzel CJ, Liu M, Ho CH, Lippman SM, Tsao AS (2010) Meta-analysis of the impact of human papillomavirus (HPV) on risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol 2:15. doi:10.1186/1758-3284-2-15
Smith EM, Pawlita M, Rubenstein LM, Haugen TH, Hamsikova E, Turek LP (2010) Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer. Int J Cancer 127:111–117
Rotnáglová E, Tachezy R, Saláková M, Procházka B, Košl’abová E, Veselá E et al (2011) HPV involvement in tonsillar cancer: prognostic significance and clinically relevant markers. Int J Cancer 129:101–110
Rubenstein LM, Smith EM, Pawlita M, Haugen TH, Hamsikova E, Turek LP (2011) Human papilomavírus serologic follow-up response and relationship to survival in head and neck cancer: a case-comparison study. Infec Agent Cancer 6:9. doi:10.1186/1750-9378-6-9
Smith EM, Rubenstein LM, Haugen TH, Pawlita M, Turek LP (2012) Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease. J Oncol. doi:10.1155./2012/571862
Méndez E (2012) Biomarkers of HPV infection in oropharyngeal carcinomas: can we find simplicity in the puzzle of complexity? Cancer Res 72:4896–4898
Acknowledgments
This work was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) [10/50733-6; 09/52031-1 and 04/12054-9] and by the European Commission [IC18-CT97-0222].
Conflict of interest
None declared.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
López, R.V.M., Levi, J.E., Eluf-Neto, J. et al. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection. Cancer Causes Control 25, 461–471 (2014). https://doi.org/10.1007/s10552-014-0348-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-014-0348-8